HIF1A and lung carcinoma: Thus, the present review focused on the anticancer effects of andrographolide, specifically on breast, colorectal and lung cancer through the NF-κB, hypoxia-inducible factor 1 (HIF-1) and the JAK/STAT signaling pathways.